| Range | 6M |
|---|---|
| First date | — |
| Last date | — |
| Open | — |
| High | — |
| Low | — |
| Close | — |
| Volume | — |
| Plotted bars | 0 |
Event records
Event records load after the price chart.
Healthcare · Pharmaceutical Retailers
The Quantellect read. Short interest is 22.38% of float with a 362.20% borrow fee. Descriptive summary of the data on this page, not a recommendation.
P/S 0.0× vs peer median 0.2×
RSI (14) 53.3 (overbought above 70, oversold below 30)
—
FINRA settlement Oct 30, 2026
Price — · As of —
| Range | 6M |
|---|---|
| First date | — |
| Last date | — |
| Open | — |
| High | — |
| Low | — |
| Close | — |
| Volume | — |
| Plotted bars | 0 |
Event records load after the price chart.
| Range | 6M |
|---|---|
| First close | — |
| Last close | — |
| High | — |
| Low | — |
| Volume | — |
POM · NASDAQ · USD
Split-adjusted · volume in shares
— · Notable price movement not available
— · Options flow not available
Insufficient data · Tide session Nov 18, 2026
Against 5 other US-listed Pharmaceutical Retailers stocks
Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%
Insufficient comparable data
Not ranked: only 5 of 5 peers report it
Not ranked: only 4 of 5 peers report it
Not ranked: only 5 of 5 peers report it
Not enough peers report profitability metrics for a group comparison.
Not ranked: only 5 of 5 peers report it
Not ranked: only 4 of 5 peers report it
Not ranked: only 5 of 5 peers report it
Not ranked: only 5 of 5 peers report it
Not enough peers report growth metrics for a group comparison.
Not ranked: only 5 of 5 peers report it
Not ranked: only 1 of 5 peers report it
Not enough peers report balance sheet metrics for a group comparison.
Not ranked: only 3 of 5 peers report it
Not ranked: only 1 of 5 peers report it
Not enough peers report returns for a group comparison.
Not ranked: only 2 of 5 peers report it
Not ranked: only 3 of 5 peers report it
Not ranked: only 3 of 5 peers report it
Compared with 5 other US-listed Pharmaceutical Retailers stocks · fundamentals as of Nov 18, 2026 · prices as of Nov 18, 2026
— · Smart-money activity not available
All smart-money activity →News and press releases are not available.
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers,
Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.